Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 491: Which of the following can cause acute tubular necrosis?

A. Radiocontrast agents
B. Amphotericin B
C. Both of the above (Correct Answer)
D. None of the above

Explanation: **Explanation:**Acute Tubular Necrosis (ATN) is a common cause of intrinsic acute kidney injury (AKI) characterized by damage to the renal tubular epithelial cells. It can be caused by ischemia or, as in this case, **nephrotoxins**.**1. Radiocontrast Agents (Option A):** Contrast-induced nephropathy is a leading cause of hospital-acquired ATN. These agents cause renal injury through two mechanisms: **direct cytotoxicity** to the tubular cells and **intense renal vasoconstriction** leading to medullary ischemia. The damage typically manifests as a rapid but often reversible decline in GFR.**2. Amphotericin B (Option B):** This "nephrotoxic" antifungal causes ATN [1] by binding to ergosterol in the cell membrane, which creates pores that increase membrane permeability. This leads to **direct tubular toxicity** (especially in the distal tubule) and **afferent arteriolar vasoconstriction**, reducing renal blood flow. It is classically associated with distal Renal Tubular Acidosis (Type 1 RTA) and significant electrolyte wasting (hypokalemia and hypomagnesemia).Since both agents are well-documented causes of drug-induced ATN, **Option C** is the correct answer.**High-Yield Clinical Pearls for NEET-PG:** * **Other common causes of ATN:** Aminoglycosides (Gentamicin), Cisplatin, NSAIDs, and Myoglobin (Rhabdomyolysis).* **Urinary Findings:** ATN is characterized by the presence of **"Muddy brown" granular casts** in the urine sediment.* **Prevention:** The most effective strategy to prevent contrast-induced ATN is **adequate hydration** (Isotonic saline) before the procedure. For Amphotericin B, using **liposomal formulations** significantly reduces nephrotoxicity [1].* **Fractional Excretion of Sodium (FeNa):** In ATN, FeNa is typically **>2%**, indicating the tubules' inability to reabsorb sodium.

Question 492: Benzodiazepine overdose in a patient presenting with coma is treated by:

A. Protamine
B. Flumazenil (Correct Answer)
C. Coumarin
D. Midazolam

Explanation: **Explanation:** **Correct Answer: B. Flumazenil** Benzodiazepines (BZDs) act by enhancing the effect of the inhibitory neurotransmitter GABA at the **GABA-A receptor**. They bind to a specific site on the receptor complex, increasing the frequency of chloride channel opening. **Flumazenil** is a competitive antagonist at the benzodiazepine binding site. It rapidly reverses the sedative, psychomotor, and respiratory-depressant effects of BZDs, making it the specific antidote for overdose. **Analysis of Incorrect Options:** * **A. Protamine:** This is the specific antidote for **Heparin** overdose. It is a highly basic protein that neutralizes the acidic heparin molecule. * **C. Coumarin:** This is a class of anticoagulants (e.g., Warfarin). It is not an antidote; rather, its toxicity is treated with Vitamin K or Fresh Frozen Plasma (FFP). * **D. Midazolam:** This is a short-acting benzodiazepine itself. Administering it would worsen the coma and respiratory depression in an overdose scenario. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Flumazenil is a competitive antagonist; it does *not* reverse the effects of Barbiturates or Alcohol (which act on different sites of the GABA receptor). * **Risk of Seizures:** Use Flumazenil with caution in patients with long-term BZD dependence or those who have co-ingested tricyclic antidepressants (TCAs), as it can precipitate **acute withdrawal seizures**. * **Half-life:** Flumazenil has a very short half-life (~1 hour). Since most BZDs have a longer duration of action, "re-sedation" can occur, requiring repeated doses or an infusion. * **Z-drugs:** Flumazenil also reverses the effects of non-benzodiazepine hypnotics like Zolpidem, Zaleplon, and Eszopiclone.

Question 493: Minimal change disease is caused by:

A. Rifampicin
B. IFN-a
C. Steroids
D. Gold (Correct Answer)

Explanation: Minimal Change Disease (MCD) is a common cause of nephrotic syndrome. While most cases are idiopathic, certain drugs can trigger secondary MCD by inducing T-cell dysfunction and podocyte injury. **Why Gold is Correct:** Gold salts (used historically for Rheumatoid Arthritis) are classic triggers for secondary glomerular diseases. While Gold is more frequently associated with **Membranous Nephropathy**, it is a well-documented cause of **Minimal Change Disease**. The drug acts as a hapten, triggering an immune response that leads to the effacement of podocyte foot processes. **Analysis of Incorrect Options:** * **Rifampicin:** This drug is most commonly associated with **Acute Interstitial Nephritis (AIN)** and occasionally Acute Tubular Necrosis (ATN) [1]. It is not a typical cause of MCD. * **IFN-̑ (Interferon-alpha):** Interferon therapy is strongly associated with **Focal Segmental Glomerulosclerosis (FSGS)**, particularly the collapsing variant, rather than MCD. * **Steroids:** Steroids are the **treatment of choice** for Minimal Change Disease, not the cause [2]. They help stabilize podocytes and decrease cytokine production by inhibiting the innate and adaptive immune systems [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Common Drug Triggers for MCD:** NSAIDs (most common), Lithium, Gold salts, and Pamidronate. * **NSAID-induced Nephrotoxicity:** Can uniquely cause a combination of **MCD and Acute Interstitial Nephritis** simultaneously. * **MCD Pathology:** Characterized by "Nil disease" on Light Microscopy, negative Immunofluorescence, and **effacement of foot processes** on Electron Microscopy. * **Hodgkin Lymphoma:** The most common malignancy associated with secondary Minimal Change Disease.

Question 494: Activated charcoal is used as an antidote in which of the following conditions?

A. Alcohol intoxication
B. Barbiturate poisoning (Correct Answer)
C. Heavy metal poisoning
D. Lead poisoning

Explanation: **Explanation:** Activated charcoal (AC) is a highly porous substance with a large surface area that acts as a **gastrointestinal decontaminant** by adsorbing toxins, thereby preventing their systemic absorption. **Why Barbiturates are the correct answer:** Barbiturates are large, organic molecules that bind effectively to the surface of activated charcoal. In the case of Phenobarbital (a long-acting barbiturate), **Multiple-Dose Activated Charcoal (MDAC)** is particularly effective. This is due to "gastrointestinal dialysis," where the charcoal in the gut lumen creates a concentration gradient that pulls the drug back from the systemic circulation into the intestine, even after absorption has occurred. **Why the other options are incorrect:** Activated charcoal is ineffective against substances that are small, highly ionized, or lack organic structures. The mnemonic **"PHAILS"** helps remember substances where AC is ineffective: * **Alcohol (Option A):** Ethanol and methanol are small, polar molecules that do not bind to charcoal. * **Heavy Metals/Lead (Options C & D):** Metals (Lead, Iron, Lithium, Mercury) and corrosives do not adsorb to AC. These require specific chelating agents (e.g., Penicillamine for Lead). **High-Yield Clinical Pearls for NEET-PG:** * **Ideal Time:** AC is most effective if administered within **1 hour** of ingestion. * **Contraindications:** Diminished bowel sounds (ileus), intestinal obstruction, or ingestion of hydrocarbons (risk of aspiration pneumonia). * **MDAC Indications:** Remember the mnemonic **"ABCD"** for drugs where multiple doses are useful: **A**ntimalarials (Quinine)/Aminophylline (Theophylline), **B**arbiturates (Phenobarbital), **C**arbamazepine, and **D**apsone/Digitalis.

Question 495: A 52-year-old man presents with jaundice and extrapyramidal symptoms. An ophthalmic examination reveals a characteristic finding. What is the most appropriate treatment for this condition?

A. BAL (British Anti-Lewisite)
B. Penicillamine (Correct Answer)
C. Calcium edetate
D. Desferrioxamine

Explanation: **Explanation:** The clinical presentation of **jaundice** (liver involvement) and **extrapyramidal symptoms** (neurological involvement), combined with a characteristic ophthalmic finding (**Kayser-Fleischer rings**), is diagnostic of **Wilson’s Disease** (Hepatolenticular degeneration). This is an autosomal recessive disorder of copper metabolism leading to toxic accumulation of copper in the liver, brain, and cornea. **Why Penicillamine is correct:** **Penicillamine** is the drug of choice for Wilson’s Disease. It is a potent **chelating agent** that binds to copper, forming a soluble complex excreted in the urine. It also induces the synthesis of metallothionein, which sequesters copper in a non-toxic form. **Analysis of Incorrect Options:** * **A. BAL (British Anti-Lewisite/Dimercaprol):** Primarily used for acute poisoning of heavy metals like **Arsenic, Mercury, and Lead**. While it can chelate copper, it is not the first-line treatment for Wilson's due to its toxicity and the requirement for IM administration. * **C. Calcium edetate (Ca-EDTA):** The preferred chelator for **Lead poisoning**. It has poor penetration into the CNS and is not effective for copper removal. * **D. Desferrioxamine:** A specific chelating agent used for **Iron toxicity** (acute poisoning or chronic overload like Thalassemia). **High-Yield Pearls for NEET-PG:** * **Kayser-Fleischer (KF) rings:** Copper deposition in the **Descemet’s membrane** of the cornea. * **Diagnosis:** Decreased serum ceruloplasmin, increased 24-hour urinary copper excretion. * **Alternative Treatment:** **Trientine** (preferred if Penicillamine is not tolerated due to side effects like nephrotoxicity or SLE-like syndrome) and **Oral Zinc** (prevents copper absorption). * **Neurological site:** The **Putamen** (Lenticular nucleus) is the most common site of brain involvement.

Question 496: All of the following can cause visual adverse effects except:

A. Ethambutol
B. Rifampicin (Correct Answer)
C. Chloroquine
D. Digoxin

Explanation: ### Explanation The correct answer is **Rifampicin**. While Rifampicin is known for causing a harmless orange-red discoloration of body secretions (tears, urine, sweat), it does **not** typically cause structural or functional visual impairment or ocular toxicity. **Why the other options are incorrect:** * **Ethambutol:** A classic cause of **optic neuritis**. It leads to a dose-dependent decrease in visual acuity and **red-green color blindness**. Patients must undergo baseline and monthly visual acuity and color vision testing. * **Chloroquine:** Known for causing **"Bull’s eye maculopathy"** due to its affinity for melanin in the retinal pigment epithelium. It can also cause corneal deposits (vortex keratopathy), which are usually reversible. * **Digoxin:** Toxicity characteristically causes **Xanthopsia** (yellowish-green tint to vision) and blurred vision with "halos" around lights. This is due to the inhibition of Na+/K+ ATPase in the retina. **High-Yield Clinical Pearls for NEET-PG:** 1. **Vigabatrin:** Associated with permanent **bilateral concentric visual field contraction** (tunnel vision). 2. **Amiodarone:** Causes **corneal micro-deposits** (vortex keratopathy/cornea verticillata) and optic neuropathy. 3. **Sildenafil:** Can cause **cyanopsia** (blue-tinted vision) due to weak inhibition of PDE-6 in the retina. 4. **Voriconazole:** Frequently causes transient visual disturbances (photopsia/blurred vision) in about 30% of patients shortly after administration. 5. **Thioridazine:** High doses can lead to **retinitis pigmentosa**.

Question 497: A patient presents with dry mouth, pupillary dilation, and warm skin. The likely drug toxicity is?

A. Organophosphate
B. Carbamazepine
C. Lithium
D. Amitriptyline (Correct Answer)

Explanation: ### ExplanationThe clinical presentation of **dry mouth** (xerostomia), **pupillary dilation** (mydriasis), and **warm, flushed skin** constitutes the classic **Anticholinergic Toxidrome** [1].**1. Why Amitriptyline is Correct:**Amitriptyline is a **Tricyclic Antidepressant (TCA)**. TCAs possess potent muscarinic receptor-blocking properties. In toxicity, this leads to competitive inhibition of acetylcholine, resulting in:* **Dry mouth/skin:** Inhibition of salivary and sweat gland secretions.* **Mydriasis:** Paralysis of the pupillary sphincter muscle.* **Warm skin:** Peripheral vasodilation and lack of sweating (anhidrosis).* *Other signs:* Tachycardia, urinary retention, and blurred vision.**2. Analysis of Incorrect Options:*** **A. Organophosphates:** These inhibit acetylcholinesterase, leading to a **cholinergic crisis**. Symptoms are the exact opposite: salivation, lacrimation, urination, diarrhea, and **miosis** (pinpoint pupils).* **B. Carbamazepine:** Toxicity primarily presents with neurological symptoms like ataxia, nystagmus, and coma. While it can have mild anticholinergic effects, it is not the classic presentation compared to TCAs.* **C. Lithium:** Toxicity is characterized by gastrointestinal distress (vomiting, diarrhea) and neurological signs like **coarse tremors**, ataxia, and seizures. It does not cause an anticholinergic toxidrome.**3. NEET-PG High-Yield Pearls:*** **TCA Toxicity Triad (The 3 Cs):** **C**onvulsions, **C**oma, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade).* **ECG Finding:** Widening of the QRS complex (>100ms) is a critical predictor of seizures and arrhythmias in TCA overdose.* **Antidote:** **Sodium Bicarbonate** is the drug of choice for TCA-induced cardiotoxicity (it reverses Na+ channel blockade).* **Mnemonic for Anticholinergic Toxicity:** "Hot as a hare, blind as a bat, dry as a bone, red as a beet, and mad as a hatter."

Question 498: What is the antidote for acute organophosphate poisoning?

A. Neostigmine
B. Atropine (Correct Answer)
C. Pilocarpine
D. Tubocurarine

Explanation: **Explanation:** Organophosphate (OP) poisoning occurs due to the irreversible inhibition of the enzyme **Acetylcholinesterase (AChE)**. This leads to a massive accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors, resulting in a "cholinergic crisis" (SLUDGE syndrome: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis). **Why Atropine is the Correct Answer:** Atropine is a **competitive muscarinic antagonist**. It crosses the blood-brain barrier and blocks the effects of excess ACh at muscarinic receptors [3]. It specifically reverses life-threatening symptoms like bradycardia, bronchospasm, and excessive bronchial secretions. In OP poisoning, Atropine is titrated until "Atropinization" is achieved (indicated by clear lungs and a heart rate >80 bpm) [3]. **Why Other Options are Incorrect:** * **Neostigmine:** This is an AChE inhibitor itself. Giving it would further increase ACh levels, worsening the toxicity. * **Pilocarpine:** This is a muscarinic agonist (cholinomimetic). It would exacerbate the cholinergic symptoms. * **Tubocurarine:** This is a skeletal muscle relaxant (nicotinic antagonist). While it acts on nicotinic receptors, it does not address the lethal muscarinic effects and can cause respiratory paralysis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Specific Antidote:** While Atropine treats muscarinic symptoms, **Pralidoxime (2-PAM)** is the "oxime" used to regenerate the enzyme AChE, provided it is given before "enzyme aging" occurs [1], [4]. 2. **Atropine does NOT** reverse muscle paralysis or weakness (nicotinic effects); only oximes can address these [2], [3]. 3. **Management Priority:** Airway management and aggressive Atropinization are the mainstays of treatment [3]. 4. **Diagnosis:** Confirmed by measuring low levels of **Pseudocholinesterase** (Butyrylcholinesterase) in the plasma [4].

Question 499: Terfenadine and astemizole, two antihistamines, were withdrawn from the market due to cardiac arrhythmias observed when they were present in high blood levels. Which of the following facts best explains these effects?

A. Concurrent use of these drugs by addicts
B. Genetic predisposition to metabolize succinylcholine slowly
C. Concurrent treatment with phenobarbital
D. Concurrent treatment with erythromycin, a macrolide antibiotic (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Concurrent treatment with erythromycin, a macrolide antibiotic.** **1. Mechanism of Toxicity (The "Why"):** Terfenadine and astemizole are second-generation antihistamines that act as prodrugs. They are normally metabolized by the hepatic cytochrome P450 enzyme **CYP3A4** into active, non-toxic metabolites (e.g., fexofenadine). [1] When administered with **CYP3A4 inhibitors** like **erythromycin** (a macrolide) [1] or ketoconazole (an antifungal) [2], the metabolism of the parent drug is blocked. This leads to high plasma levels of the parent compound, which blocks **delayed rectifier potassium channels (hERG channels)** in the heart. This action prolongs the QT interval, leading to a life-threatening ventricular arrhythmia known as **Torsades de Pointes (TdP)**. [3] **2. Analysis of Incorrect Options:** * **Option A:** Drug addiction is not a specific risk factor for terfenadine-induced arrhythmias unless the abused substance is a CYP3A4 inhibitor. * **Option B:** Slow metabolism of succinylcholine is due to **pseudocholinesterase deficiency**, which leads to prolonged apnea, not cardiac arrhythmias with antihistamines. * **Option C:** Phenobarbital is a **CYP450 inducer**. It would speed up the metabolism of terfenadine, thereby *decreasing* the risk of toxicity rather than increasing it. [2] **3. NEET-PG High-Yield Pearls:** * **Fexofenadine** is the active metabolite of terfenadine; it is safe because it does not block cardiac K+ channels. * **Other CYP3A4 inhibitors to remember:** Clarithromycin, Ketoconazole, Itraconazole, and Grapefruit juice. [2] * **Drugs causing QT prolongation:** Macrolides, Fluoroquinolones, Antipsychotics (Haloperidol), and Class IA/III Antiarrhythmics. * **Treatment of choice for Torsades de Pointes:** Intravenous Magnesium Sulfate.

Question 500: Which of the following is true regarding opioid-induced seizures?

A. They occur at therapeutic doses.
B. Children are more susceptible. (Correct Answer)
C. Seizures occur only with mu-opioid agonists.
D. Diazepam is the drug of choice.

Explanation: **Explanation:** Opioids generally act as CNS depressants; however, they can induce seizures through the inhibition of GABAergic interneurons (disinhibition) or the accumulation of toxic metabolites. **1. Why Option B is Correct:** Children are significantly more susceptible to opioid-induced neurotoxicity and seizures. This is primarily due to an **immature blood-brain barrier (BBB)** and developing metabolic pathways. In neonates and infants, higher concentrations of the drug reach the CNS, and the seizure threshold is lower compared to adults. **2. Why Incorrect Options are Wrong:** * **Option A:** Seizures typically occur at **supratherapeutic doses**, in cases of acute overdose, or in patients with renal failure where metabolites accumulate. They are rarely seen at standard therapeutic doses. * **Option C:** While mu-agonists are common culprits, seizures are notably associated with **Meperidine (Pethidine)** via its metabolite **normeperidine**, and **Tramadol** (which has complex mechanisms involving serotonin and NE reuptake). It is not exclusive to pure mu-agonists. * **Option D:** While benzodiazepines can manage the motor symptoms, **Naloxone** is the definitive initial treatment for opioid toxicity. However, if seizures are specifically caused by normeperidine, naloxone may be less effective or even lower the seizure threshold further; in such specific toxicities, anticonvulsants are used, but Naloxone remains the primary antidote for general opioid overdose. **Clinical Pearls for NEET-PG:** * **Meperidine (Pethidine):** Avoid in patients with renal failure; normeperidine accumulation causes tremors, myoclonus, and seizures. * **Tramadol:** High risk of seizures even at therapeutic doses if combined with SSRIs (Serotonin Syndrome). * **Morphine-3-Glucuronide (M3G):** The metabolite of morphine responsible for neuroexcitatory effects (allodynia/seizures), unlike M6G which provides analgesia.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free